| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 34.646 | 11.159 | 14.718 | 3.962 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 34.646 | 11.159 | 14.718 | 3.962 | 0 |
| Total Expenses - EUR | - | - | - | - | 478 | 45.550 | 3.021 | 13.812 | 6.410 | 297 |
| Gross Profit/Loss - EUR | - | - | - | - | -478 | -10.904 | 8.137 | 906 | -2.448 | -297 |
| Net Profit/Loss - EUR | - | - | - | - | -478 | -11.944 | 7.803 | 465 | -2.448 | -297 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ciemedi S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 37.678 | 61.069 | 68.482 | 65.556 | 60.526 | 60.188 |
| Inventories | - | - | - | - | 37.635 | 44.685 | 47.709 | 47.857 | 44.898 | 44.647 |
| Receivables | - | - | - | - | 56 | 16.351 | 17.257 | 17.191 | 15.122 | 15.038 |
| Cash | - | - | - | - | -13 | 33 | 3.516 | 507 | 505 | 503 |
| Shareholders Funds | - | - | - | - | -433 | -12.369 | -4.292 | -3.840 | -6.277 | -6.539 |
| Social Capital | - | - | - | - | 44 | 43 | 42 | 43 | 42 | 0 |
| Debts | - | - | - | - | 38.111 | 73.437 | 72.774 | 69.396 | 66.802 | 66.726 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4613 - 4613" | |||||||||
| CAEN Financial Year |
4613
|
|||||||||
Comments - Ciemedi S.r.l.